Letter to the Editor July 20, 2017

Loss of Meaning in the Era of DSM and Psychopharmacology

Prim Care Companion CNS Disord 2017;19(4):17l02092

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

To the Editor: When addressing changes in symptom severity in patients with psychiatric disorders, it is important to consider psychosocial stressors before jumping to pharmaceutical interventions. Here, 2 cases are presented to illustrate this point.

Case 1. Ms A is a 54-year-old woman with a DSM-5 diagnosis of recurrent major depressive disorder in remission on fluoxetine 20 mg daily.